Alexander V. Belyavsky
New York Blood Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Alexander V. Belyavsky.
FEBS Letters | 1996
Anna E. Popsueva; Marina V. Zinovjeva; Jan W.M. Visser; J. Mark J. M. Zijlmans; Willem E. Fibbe; Alexander V. Belyavsky
A novel cDNA encoding a putative secreted protein was isolated from murine bone marrow. The encoded protein named MCLP ( urine athelin‐ ike rotein) was found to be highly homologous to the pig cathelin, and to four neutrophil antimicrobial polypeptides: CAP 18, indolicidin, Bac 5 and FALL‐39. Secondary structure prediction studies identified a highly cationic region in the C‐terminal part of prepro‐MCLP with a tendency to adopt an amphipathic α‐helical conformation, as observed in many antimicrobial peptides. However, no antibacterial activity was observed with the synthetic peptide corresponding to this region of MCLP.
FEBS Letters | 1995
M.A. Ershler; I.M. Samokhvalov; Alexander V. Belyavsky; Jan W.M. Visser
Recently, we and others have cloned cDNAs encoding a second member of the Csk family of inhibitory protein kinases, which we termed Bhk [M.A. Ershler et al. (1994) Dokl. Akad. Nauk. 339, 679–683]. In the present study, two new distinct types of bhk mRNA were found in addition to the third form described previously. Analysis of the bhk genomic structure established that three exons participate in the alternative splicing of bhk mRNA.
Methods in molecular medicine | 2002
Alexander V. Belyavsky; Sergey Shmelkov; Jan W.M. Visser
Differential activity of genes is one of the major mechanisms underlying a vast array of biological phenomena. Classical genetic approaches (from phenotypes to genes) have proven their exquisite potential for dissection of complex signaling pathways regulating the development of organisms and the functioning of individual cells. In recent years, with the advent of a number of techniques for studying gene function, the reverse genetics approach (from genes to phenotypes) has received broad acceptance. One of the advantages of this strategy is that it makes genes, whose dysfunction either does not produce an evident phenotype or is lethal, amenable to analysis. Reverse genetics has spearheaded the development of procedures for identification of candidate genes for this type of analysis by detecting spatial or temporal changes in geneexpression patterns. A significant range of methods have been proposed (1-7); in particular, the advent of microarray hybridization techniques promises to increase gene-expression analysis throughput by two or more orders of magnitude (8,9). Some of these procedures have been used to identify genes expressed differentially during hematopoiesis (10,11).
Nucleic Acids Research | 1995
Natalia B. Ivanova; Alexander V. Belyavsky
Nucleic Acids Research | 1991
Yuri V. Postnikov; Valentin V. Shick; Alexander V. Belyavsky; Konstantin Khrapko; Konstantin Brodolin; Tatjana A. Nikolskaya; Andrei D. Mirzabekov
Nucleic Acids Research | 1982
Vadim Karpov; Sergei G. Bavykin; Olga V. Preobrazhenskaya; Alexander V. Belyavsky; Andrei D. Mirzabekov
Nucleic Acids Research | 1985
Sergei G. Bavykin; Sergei I. Usachenko; Alla I. Lishanskaya; Valentin V. Shick; Alexander V. Belyavsky; Igor M. Undritsov; Alexei A. Strokov; Irina A. Zalenskaya; Andrei D. Mirzabekov
Experimental Hematology | 2000
Marina Zinovyeva; J.Mark J.M. Zijlmans; Willem E. Fibbe; Jan W.M. Visser; Alexander V. Belyavsky
Archive | 1997
Alexander V. Belyavsky; Natalia B. Ivanova
Gene | 2004
Marina Zinovyeva; Elena Sveshnikova; Jan W.M. Visser; Alexander V. Belyavsky